Literature DB >> 23582269

The role of memory-related gene WWC1 (KIBRA) in lifetime posttraumatic stress disorder: evidence from two independent samples from African conflict regions.

Sarah Wilker1, Stephan Kolassa, Christian Vogler, Birke Lingenfelder, Thomas Elbert, Andreas Papassotiropoulos, Dominique J-F de Quervain, Iris-Tatjana Kolassa.   

Abstract

BACKGROUND: Posttraumatic stress disorder (PTSD) results from the formation of a strong memory for the sensory-perceptual and affective representations of traumatic experiences, which is detached from the corresponding autobiographical context information. Because WWC1, the gene encoding protein KIBRA, is associated with long-term memory performance, we hypothesized that common WWC1 alleles influence the risk for a lifetime diagnosis of PTSD.
METHODS: Traumatic load and diagnosis of current and lifetime PTSD were assessed in two independent African samples of survivors from conflict zones who had faced severe trauma (n = 392, Rwanda, and n = 399, Northern Uganda, respectively). Array-based single nucleotide polymorphism (SNP) genotyping was performed. The influence of WWC1 tagging SNPs and traumatic load on lifetime PTSD was estimated by means of logistic regression models with correction for multiple comparisons in the Rwandan sample. Replication analysis was performed in the independent Ugandan sample.
RESULTS: An association of two neighboring SNPs in almost complete linkage disequilibrium, rs10038727 and rs4576167, with lifetime PTSD was discovered in the Rwandan sample. Although each traumatic event added to the probability of lifetime PTSD in a dose-dependent manner in both genotype groups, carriers of the minor allele of both SNPs displayed a diminished risk (p = .007, odds ratio = .29 [95% confidence interval = .15-.54]). This effect was confirmed in the independent Ugandan sample.
CONCLUSIONS: This study reveals an association between two WWC1 SNPs and the likelihood of PTSD development, indicating that this memory-related gene might be involved in processes that occur in response to traumatic stress and influence the strengthening of fear memories.
Copyright © 2013 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetics; KIBRA; WWC1; memory; posttraumatic stress disorder; risk; trauma

Mesh:

Substances:

Year:  2013        PMID: 23582269     DOI: 10.1016/j.biopsych.2013.02.022

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  From candidate genes to genome-wide association: the challenges and promise of posttraumatic stress disorder genetic studies.

Authors:  Karestan C Koenen; Laramie E Duncan; Israel Liberzon; Kerry J Ressler
Journal:  Biol Psychiatry       Date:  2013-11-01       Impact factor: 13.382

2.  Genetic Association Between KIBRA Polymorphism and Alzheimer's Disease with in a Japanese Population.

Authors:  Eri Kawai; Nobuto Shibata; Tomoyuki Nagata; Shunichiro Shinagawa; Kenji Tagai; Kenji Tgai; Tohru Ohnuma; Hiromi Shimazaki; Aiko Toda; Koji Kasanuki; Toshiki Takayama; Ayako Suzuki; Kazuhiko Nakayama; Hisashi Yamada; Heii Arai
Journal:  Neuromolecular Med       Date:  2015-03-24       Impact factor: 3.843

3.  Further support for an association between the memory-related gene WWC1 and posttraumatic stress disorder: results from the Detroit Neighborhood Health Study.

Authors:  Jennifer A Sumner; Robert H Pietrzak; Allison E Aiello; Monica Uddin; Derek E Wildman; Sandro Galea; Karestan C Koenen
Journal:  Biol Psychiatry       Date:  2014-05-15       Impact factor: 13.382

4.  The role of FKBP5 genotype in moderating long-term effectiveness of exposure-based psychotherapy for posttraumatic stress disorder.

Authors:  S Wilker; A Pfeiffer; S Kolassa; T Elbert; B Lingenfelder; E Ovuga; A Papassotiropoulos; D de Quervain; I-T Kolassa
Journal:  Transl Psychiatry       Date:  2014-06-24       Impact factor: 6.222

5.  Integrated genetic, epigenetic, and gene set enrichment analyses identify NOTCH as a potential mediator for PTSD risk after trauma: Results from two independent African cohorts.

Authors:  Daniela Conrad; Sarah Wilker; Anna Schneider; Alexander Karabatsiakis; Anett Pfeiffer; Stephan Kolassa; Virginie Freytag; Vanja Vukojevic; Christian Vogler; Annette Milnik; Andreas Papassotiropoulos; Dominique J-F de Quervain; Thomas Elbert; Iris-Tatjana Kolassa
Journal:  Psychophysiology       Date:  2018-10-17       Impact factor: 4.016

6.  Genetic variation is associated with PTSD risk and aversive memory: Evidence from two trauma-Exposed African samples and one healthy European sample.

Authors:  Sarah Wilker; Anna Schneider; Daniela Conrad; Anett Pfeiffer; Christina Boeck; Birke Lingenfelder; Virginie Freytag; Vanja Vukojevic; Christian Vogler; Annette Milnik; Andreas Papassotiropoulos; Dominique J-F de Quervain; Thomas Elbert; Stephan Kolassa; Iris-Tatjana Kolassa
Journal:  Transl Psychiatry       Date:  2018-11-22       Impact factor: 6.222

7.  Does cumulative exposure to traumatic stressors predict treatment outcome of community-implemented exposure-based therapy for PTSD?

Authors:  Anna Schneider; Anett Pfeiffer; Daniela Conrad; Thomas Elbert; Iris-Tatjana Kolassa; Sarah Wilker
Journal:  Eur J Psychotraumatol       Date:  2020-09-15

8.  Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression.

Authors:  Monika Talarowska; Janusz Szemraj; Małgorzata Kowalczyk; Piotr Gałecki
Journal:  Med Sci Monit       Date:  2016-01-15

9.  Stigmatization Is Associated With Increased PTSD Risk After Traumatic Stress and Diminished Likelihood of Spontaneous Remission-A Study With East-African Conflict Survivors.

Authors:  Anna Schneider; Daniela Conrad; Anett Pfeiffer; Thomas Elbert; Iris-Tatjana Kolassa; Sarah Wilker
Journal:  Front Psychiatry       Date:  2018-10-10       Impact factor: 4.157

10.  The role of KIBRA in reconstructive episodic memory.

Authors:  Armin Zlomuzica; Friederike Preusser; Susanna Roberts; Marcella L Woud; Kathryn J Lester; Ekrem Dere; Thalia C Eley; Jürgen Margraf
Journal:  Mol Med       Date:  2018-03-15       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.